(Q39490917)

English

Bluetongue virus serotype 8 virus-like particles protect sheep against virulent virus infection as a single or multi-serotype cocktail immunogen

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 September 2017

Bluetongue virus serotype 8 virus-like particles protect sheep against virulent virus infection as a single or multi-serotype cocktail immunogen (English)

1 reference

Europe PubMed Central

12 September 2017

bluetongue virus

0 references

Stéphan Zientara

8

object named as

Stéphan Zientara

0 references

9

object named as

Polly Roy

1 reference

Europe PubMed Central

12 September 2017

Corinne Sailleau

3

object named as

Corinne Sailleau

1 reference

Europe PubMed Central

12 September 2017

5

object named as

Cyril Viarouge

1 reference

Europe PubMed Central

12 September 2017

Emmanuel Breard

4

object named as

Emmanuel Bréard

1 reference

Europe PubMed Central

12 September 2017

Alexandra Desprat

6

object named as

Alexandra Desprat

1 reference

Europe PubMed Central

12 September 2017

author name string

Meredith Stewart

1

1 reference

Europe PubMed Central

12 September 2017

Eric Dubois

2

1 reference

Europe PubMed Central

12 September 2017

Richard Thiéry

7

1 reference

Europe PubMed Central

12 September 2017

language of work or name

0 references

publication date

14 November 2012

1 reference

Europe PubMed Central

12 September 2017

1 reference

Europe PubMed Central

12 September 2017

31

1 reference

Europe PubMed Central

12 September 2017

3

1 reference

Europe PubMed Central

12 September 2017

553-558

1 reference

Europe PubMed Central

12 September 2017

Culicoides and the emergence of bluetongue virus in northern Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Toggenburg Orbivirus, a new bluetongue virus: initial detection, first observations in field and experimental infection of goats and sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Bluetongue in Europe and the Mediterranean Basin: history of occurrence prior to 2006.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Field observations during the bluetongue serotype 8 epidemic in 2006. I. Detection of first outbreaks and clinical signs in sheep and cattle in Belgium, France and the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Bluetongue in Europe: past, present and future

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Comparative safety study of three inactivated BTV-8 vaccines in sheep and cattle under field conditions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Possible adverse reactions in sheep after vaccination with inactivated BTV vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Vaccines against bluetongue in Europe.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

A European field strain of bluetongue virus derived from two parental vaccine strains by genome segment reassortment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Genetically engineered particulate virus-like structures and their use as vaccine delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Protective efficacy of virus-like particles for bluetongue disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Validation of a novel approach for the rapid production of immunogenic virus-like particles for bluetongue virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Characterization of protection afforded by a bivalent virus-like particle vaccine against bluetongue virus serotypes 1 and 4 in sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Multigene expression of protein complexes by iterative modification of genomic Bacmid DNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Recombinant capripoxviruses expressing proteins of bluetongue virus: evaluation of immune responses and protection in small ruminants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Bluetongue in Belgium, 2006.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

A side effect of decreased fertility associated with vaccination against bluetongue virus serotype 8 in Holstein dairy cows.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Bluetongue virus RNA detection by RT-qPCR in blood samples of sheep vaccinated with a commercially available inactivated BTV-8 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Multiserotype protection elicited by a combinatorial prime-boost vaccination strategy against bluetongue virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Protective efficacy of live-attenuated influenza vaccine (multivalent, Ann Arbor strain): a literature review addressing interference

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Evaluation of interferences between dengue vaccine serotypes in a monkey model.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Immunologic interference from sequential administration of live attenuated alphavirus vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.11.016

1 reference

Europe PubMed Central

12 September 2017

1 reference

Europe PubMed Central

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39490917&oldid=1951019700"